News
YourChoice Therapeutics, a biotech company based in California, has reported promising safety data from an early-stage ...
Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results